We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Preventing Type II Diabetes Requires Putting the Brakes on Zinc Transport Protein

By LabMedica International staff writers
Posted on 29 Dec 2016
Print article
Image: An illustration of the high-risk (left) and low-risk (right) versions of the ZnT8 protein as it transports zinc ions (purple spheres) across a cell membrane, where it binds with insulin (green and yellow). The letters show the difference in the DNA code that produces the variation in proteins (Photo courtesy of Drs. Chengfeng Merriman and Dax Fu, Johns Hopkins University).
Image: An illustration of the high-risk (left) and low-risk (right) versions of the ZnT8 protein as it transports zinc ions (purple spheres) across a cell membrane, where it binds with insulin (green and yellow). The letters show the difference in the DNA code that produces the variation in proteins (Photo courtesy of Drs. Chengfeng Merriman and Dax Fu, Johns Hopkins University).
The enhanced activity of a zinc transport protein encoded by a fairly common gene variant has been linked to heightened risk of developing type II diabetes.

Zinc is a critical element for insulin storage in the secretory granules of pancreatic beta cells. The islet-specific zinc transporter ZnT8 mediates granular sequestration of zinc ions. A genetic variant of human ZnT8 arising from a single nonsynonymous nucleotide change in the SLC30A8 (solute carrier family 30 member 8) gene contributes to increased susceptibility to type II diabetes, but it has remained unclear how the high-risk variant (R325), which is also a higher-frequency allele, is correlated with zinc transport activity.

Previous genomics studies have shown that variants of SLC30A8 were closely related to risk of developing type II diabetes. Individuals with the more common R325 version of the gene had a 12% greater likelihood of developing the disease than did those with the less common W325 form. Individuals with a very rare, inactive form of the gene had very low risk of developing type II diabetes.

In the current study, investigators at Johns Hopkins University (Baltimore, MD, USA) compared the activity of R325 with that of the low-risk W325 ZnT8 variant. They reported in the November 8, 2016, online edition of the Journal of Biological Chemistry that the R325 variant was some 57% more active than the W325 form following induced expression in HEK293 cells.

Over a broad range of permissive lipid compositions, the R325 variant consistently exhibited accelerated zinc transport kinetics versus the W form. In agreement with the human genetic finding that rare loss-of-function (LOF) mutations in ZnT8 were associated with reduced type II diabetes risk, these results suggested that the common high-risk R325 variant was hyperactive.

"Given that type II diabetes is a growing global epidemic, it has long seemed that a drug targeting the protein SLC30A8 makes, namely ZnT8 or zinc transporter 8, would potentially have a huge impact," said senior author Dr. Dax Fu, associate professor of physiology at Johns Hopkins University. "The problem was that studies on ZnT8 had not clarified whether the protein needed to be souped up or slowed down to reduce risk. In this case, breaking the "speed limit" brings disease risk."

Related Links:
Johns Hopkins University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.